When does BIOATLA INC (BCAB) report earnings?
BIOATLA INC (BCAB) will report earnings on 2026-05-04.
BIOATLA INC (BCAB) Forecast, Price Target & Analyst Ratings
NASDAQ:BCAB • US09077B1044
Current stock price
0.1304 USD
0 (-3.12%)
At close:
0.13 USD
0 (-0.31%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOATLA INC (BCAB).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.20
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.13 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
BCAB was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BCAB.
In the previous month the buy percentage consensus was at a similar level.
BCAB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-13 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-03-31 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-09-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-02 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | JMP Securities | Reiterate | Outperform -> Outperform |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-04-03 | JP Morgan | Maintains | Overweight |
| 2023-03-28 | BTIG | Maintains | Buy |
| 2023-03-27 | JMP Securities | Maintains | Outperform |
| 2023-03-24 | EF Hutton | Reiterate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.20
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 21.54%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
BCAB is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 11M | -100.00% | |||||||||
| EBITDA YoY % growth | -106.94M -12.44% | -128.466M -20.13% | -73.018M 43.16% | -112.2M -53.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -108.14M -12.13% | -129.687M -19.93% | -73.943M 42.98% | -74.462M -0.70% | -76.212M -2.35% | -94.592M -24.12% | -72.544M 23.31% | -78.107M -7.67% | -89.498M -14.58% | -99.993M -11.73% | -106.293M -6.30% | |
| Operating Margin | N/A | N/A | -672.21% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -2.74 0.72% | -2.59 5.47% | -1.44 44.40% | -1.10 29.86% | -0.94 7.09% | -1.19 -27.17% | -0.92 23.08% | -0.98 -6.67% | -1.12 -14.58% | -1.25 -11.82% | -1.33 -5.69% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 21.54% | -0.17 45.81% | -0.14 47.11% | -0.29 -81.69% |
| Revenue Q2Q % growth | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.985M 28.13% | -12.015M 35.57% | -12.045M 12.65% | -13.28M 30.42% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
5.41%
EPS Next 5 Year
5.71%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOATLA INC / BCAB Forecast FAQ
What are the consensus estimates for BCAB stock next earnings?
The consensus EPS estimate for the next earnings of BIOATLA INC (BCAB) is -0.2 USD and the consensus revenue estimate is 0 USD.
Can you provide the expected long term growth rate for BIOATLA INC stock?
The expected long term growth rate for BIOATLA INC (BCAB) is -25.99%.